Immune Therapeutics, Inc. (IMUN) Steadfast in Efforts Leveraging the Body’s Immune System on Continent of Africa
Immune Therapeutics, Inc. (OTCQB: IMUN) is positioned as a specialty pharmaceutical company focused on manufacturing, marketing and distributing novel patented therapies to fight chronic, life-threatening diseases. The company achieves this by way of the activation and modulation of the body’s immune system. Immune Therapeutics’ technology platform is built on two different immunotherapies, Low Dose Naltrexone (LDN) and Methionine-Enkephalin (MENK). These therapies have required decades to develop thanks to work at institutions like the Pennsylvania State University Medical School at Hershey, the State University of New York, the University of Chicago, and the Multiple Sclerosis Center at UCSF. Spearheading efforts at…